The global cannabis testing market in terms of revenue was estimated to be worth $1.8 billion in 2024 and is poised to reach $4.0 billion by 2029, growing at a CAGR of 17.2% from 2024 to 2029. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics.
Download an Illustrative overview
Products segment held the highest estimated share of the cannabis testing market.
Based on product & software, the cannabis testing market is segmented into products (analytical instruments {chromatography instruments [liquid chromatography, gas chromatography & other chromatography instruments], spectroscopy instruments [mass spectrometry instruments & atomic spectroscopy instruments] & other analytical instruments} and consumables {chromatography columns, standards and CRMS, sample preparation products and other consumables) and software. The product segment accounted for the largest share of the cannabis testing market. Market growth is driven by technological advancements providing sophisticated tools for precise analysis, ensuring compliance and quality control, and the expanding legalization of cannabis products. Additionally, increasing requirements for potency labeling and pesticide screening fuel the demand for specialized consumables, further propelling growth in the cannabis testing market. For example, Thermo Fisher Scientific Inc. launched the Thermo Scientific SureSTART consumables portfolio consisting of vials, well plates, caps, inserts, kits, and mats to improve analytical performance and sample security for chromatography and mass spectrometry users in routine and research labs in clinical, food, pharma, biopharma, environmental, and academic sectors.
High growth of services segment attributed to potency testing services.
Based on service, the cannabis testing market is broadly segmented into terpene profiling, microbial analysis, residual solvent analysis, potency testing, heavy metal testing, pesticide screening, and other services. potency testing accounted for the largest share of the cannabis testing services market. The high growth of this segment is due to stringent regulatory requirements ensuring accurate THC and CBD levels. This is crucial for product labeling, consumer safety, and compliance, driving demand from producers and dispensaries seeking to meet legal standards and provide reliable, high-quality products.
Services take away the largest estimated share of the end-user segment
Based on end users, the cannabis testing market is classified into segmented into product & software end users (cannabis testing laboratories {small-scale laboratories, medium-scale laboratories, large-scale laboratories} and research institutes) and service end users (cannabis drug manufacturers & dispensaries, cannabis cultivators/growers). the service end users segment was predicted to account for the highest share of the global cannabis testing market. The large share of this end user segment is due to the rising consumer awareness of quality and safety, rising legalization of cannabis, stringent regulatory standards, and technological advancements in cannabis testing.
During the forecast period, North America displayed lucrative market growth.
North America accounted for the largest share of 65.5% of the cannabis testing market. The North American market is projected to reach a value of USD 2.6 billion by 2029 from an estimated value of USD 1.2 million in 2024, at a CAGR of 17.3% during the forecast period. The region leads the cannabis testing market due to stringent regulatory standards, robust infrastructure, and widespread legalization of cannabis for medical and recreational purposes. Additionally, North America’s advanced R&D capabilities and evolving consumer demand for quality assurance drive its prominence in this growing sector.
Key Market Players
The global cannabis testing market comprises many key market players competing for markets shares like Agilent Technologies, Inc. (US), Shimadzu Corporation (Japan), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Waters Corporation (US), Restek Corporation (US), SGS SA (Switzerland), Merck KGaA (Germany), PerkinElmer, Inc. (US), Hamilton Company (US), Sigma Analytical Services (Canada), SC Labs (US), PharmLabs LLC (US), MCS, Inc. (US), ProVerde Laboratories (US), and Eurofins Scientific (Luxembourg).
Shimadzu Corporation (Japan)
Shimadzu, one of the leading players in the cannabis testing market, employs multiple strategies to maintain business dominance. Firstly, it allocates substantial resources to research and development, creating innovative testing solutions tailored to the evolving cannabis industry. Secondly, strategic partnerships with regulatory bodies and industry leaders enhance its credibility and market presence. Thirdly, Shimadzu emphasizes customer-centric approaches by providing comprehensive support services, including training and technical assistance, ensuring optimal use of its testing equipment.
Agilent Technologies, Inc. (US)
Agilent’s cutting-edge analytical instruments offer precise cannabinoid profiling, ensuring compliance with stringent regulatory standards. For instance, its HPLC systems deliver accurate THC and CBD quantification, which is crucial for potency labeling and enhancing consumer trust and regulatory compliance. Additionally, with decades of experience in analytical chemistry, Agilent provides tailored solutions for cannabis testing labs, addressing unique challenges such as sample complexity and matrix interference. Its widespread distribution network ensures accessibility to its products, facilitating market penetration even in emerging cannabis markets like Europe and Asia. Additionally, the company forms strategic alliances with cannabis industry stakeholders, such as testing labs and regulatory bodies, to gain insights into market trends and regulatory requirements. Collaborations also facilitate the development of customized solutions tailored to specific market segments.
Get 10% Free Customization on this Report:
The primary interviews conducted for this report can be categorized as follows:
- By Respondent: Supply Side- 70%, and Demand Side - 30%
- By Designation (Supply Side): Managers - 45%, CXOs & Directors - 30%, Executives- 25%
- By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10%, MEA- 5%
Content Source:
https://www.marketsandmarkets.com/ResearchInsight/cannabis-testing-market.asp
https://www.marketsandmarkets.com/PressReleases/cannabis-testing.asp
